Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]        
Revenues $ 17,158,000 $ 7,690,000 $ 34,998,000 $ 13,961,000
Cost of sales 13,050,000 6,648,000 26,942,000 11,581,000
Gross profit 4,108,000 1,042,000 8,056,000 2,380,000
Operating expenses:        
Selling and administrative 4,250,000 4,000,000 8,786,000 7,498,000
Research and development 1,162,000 2,088,000 2,385,000 4,055,000
Total operating expenses 5,412,000 6,088,000 11,171,000 11,553,000
Operating loss (1,304,000) (5,046,000) (3,115,000) (9,173,000)
Other income 8,000 8,000
Interest expense (385,000) (31,000) (713,000) (34,000)
Net loss $ (1,681,000) $ (5,077,000) $ (3,820,000) $ (9,207,000)
Net loss per share - basic and diluted $ (0.10) $ (0.32) $ (0.24) $ (0.62)
Weighted average number of common shares outstanding - basic and diluted 16,020,183 15,987,502 16,008,740 14,895,989